Oral vs. Injectable GLP-1s: Which Is Actually Cheaper?
MadeMed's oral semaglutide starts at $99/mo. GobyMeds' injectable semaglutide is also $99/mo. Same price, completely different product. We compare pricing across both formats using our verified provider list, and explain the one absorption-science caveat that matters more than price when you're choosing between a pill and a needle.
Injectable Pricing, Side by Side
| Provider | Semaglutide | Tirzepatide | Status |
|---|---|---|---|
| Telos Rx | $49–199/mo | $49–199/mo | Clean |
| GobyMeds | $99/mo | $133/mo | Clean |
| Yucca Health | $175/mo | $258/mo | Clean |
| Care Bare Rx | ~$179–199/mo | ~$179–199/mo | Clean |
| Sprout Health | $155/mo* | $199/mo* | FDA letter |
| Strut Health | $149–289/mo | — | FDA letter |
| MEDVi | $179/mo → $299 | $279/mo → $399 | FDA letter |
| Direct Meds | $297/mo | $399/mo | FDA letter |
*Promotional rate — see our Top 10 comparison for reversion pricing.
Oral / Sublingual Pricing, Side by Side
| Provider | Semaglutide | Tirzepatide | Status |
|---|---|---|---|
| MadeMed | $99–169/mo | $229/mo | Clean |
| Telos Rx | — | $49–199/mo | Clean |
| Wellorithm | from $147/mo** | from $249/mo** | Clean |
| Strut Health | $99–149/mo | $250–400/mo | FDA letter |
| Direct Meds | $179/mo | — | FDA letter |
| MEDVi | $249/mo → $369 | — | FDA letter |
**Wellorithm doesn't clearly publish which of its plans are oral vs. injectable — confirm directly before enrolling.
So Which Is Actually Cheaper?
Looking only at providers with a clean FDA record: injectable semaglutide runs roughly $49–199/mo, and oral semaglutide runs roughly $99–169/mo. They overlap almost entirely — format alone doesn't predict price in this market. What actually moves the number is commitment length (Telos Rx's annual plan), whether a membership fee is bundled in, and how aggressively a provider prices to acquire new customers.
Tirzepatide tends to cost more than semaglutide regardless of format, usually by $50–150/mo, because the compound itself is more expensive to source. That premium shows up whether you're taking it as an injection or a sublingual tablet.
The one thing that matters more than price
Injectable semaglutide and tirzepatide have the most real-world use and data behind them, simply because that's how these medications have been administered the longest. Oral and sublingual compounded formats are newer and the absorption science is less settled — compounded oral tirzepatide in particular does not have an FDA-approved equivalent, and there's ongoing legal and scientific debate about how well it's actually absorbed compared to injection. This is different from FDA-approved oral semaglutide (Rybelsus), which uses a specific absorption technology that compounded oral versions don't replicate.
None of this means oral options don't work. It means the format switch is a bigger decision than the price difference suggests, and it's worth asking any provider directly what their oral product's absorption data actually shows — not just what it costs.
Which Format Is Right for You?
Consider injectable if:
- You want the format with the longest real-world track record
- You're not needle-averse or have done injections before
- You want access to the widest range of clean, verified providers
Consider oral/sublingual if:
- You specifically want to avoid needles
- You're comfortable asking a provider detailed questions about absorption and format
- You understand oral tirzepatide in particular has less established absorption data
If you want to compare specific providers head to head after choosing a format, our Top 10 comparison has the full write-up on all eight providers above.
Frequently Asked Questions
Is oral GLP-1 medication as effective as injectable?
For FDA-approved oral semaglutide (Rybelsus), yes — it uses a specific absorption technology validated in clinical trials. For compounded oral or sublingual GLP-1 products, the absorption data is much thinner, and compounded oral tirzepatide specifically has no FDA-approved equivalent to compare against. Ask any provider what data supports their specific oral product before assuming it works the same as an injection.
Why is tirzepatide consistently more expensive than semaglutide?
Tirzepatide is a newer, more complex molecule to compound than semaglutide, which pushes up the cost of goods for providers regardless of format. That's why you'll see a $50–150/mo premium for tirzepatide across almost every provider on this page.
Does a lower price mean lower quality?
Not necessarily — price differences mostly reflect business model choices (membership fees, commitment length, promotional pricing) rather than product quality. What matters more is whether the provider is transparent about its compounding pharmacy and currently has a clean FDA compliance record, which is why we track that separately from price on this site.